AbCellera Biologics (ABCL) is now covered by JonesTrading. They set a "buy" rating and a $11.00 price target on the stock.
AbCellera (ABCL): Among the Stocks That Could 10x Over the Next 5 Years [Yahoo! Finance]
AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026
CRA: Here's the TFSA Contribution Room for 2026 and Why Now Is the Best Time to Use It [Yahoo! Finance Canada]
AbCellera Biologics Eyes Integrated Biotech Shift; ABCL635 Phase II Data Due in Q3 at Forum [Yahoo! Finance]